Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy

BACKGROUND: The outcome of patients after radiotherapy (RT) for localized prostate cancer in case of prostate-specific antigen (PSA) progression during primary hormonal therapy (HT) is not well known. METHODS: A group of 27 patients presenting with PSA progression during primary HT for local prostat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinkawa, Michael, Piroth, Marc D, Holy, Richard, Djukic, Victoria, Klotz, Jens, Pfister, David, Heidenreich, Axel, Eble, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551819/
https://www.ncbi.nlm.nih.gov/pubmed/23227960
http://dx.doi.org/10.1186/1748-717X-7-209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551819/
https://www.ncbi.nlm.nih.gov/pubmed/23227960
http://dx.doi.org/10.1186/1748-717X-7-209

Ejemplares similares